nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—Ketonuria—Metformin—polycystic ovary syndrome	0.0961	0.197	CcSEcCtD
Propafenone—White blood cell count increased—Metformin—polycystic ovary syndrome	0.0451	0.0926	CcSEcCtD
Propafenone—Angina unstable—Metformin—polycystic ovary syndrome	0.0359	0.0736	CcSEcCtD
Propafenone—Nail disorder—Metformin—polycystic ovary syndrome	0.014	0.0287	CcSEcCtD
Propafenone—Blood disorder—Metformin—polycystic ovary syndrome	0.0108	0.0223	CcSEcCtD
Propafenone—CYP1A2—urine—polycystic ovary syndrome	0.0107	0.117	CbGeAlD
Propafenone—Contusion—Metformin—polycystic ovary syndrome	0.0104	0.0213	CcSEcCtD
Propafenone—CYP2C9—urine—polycystic ovary syndrome	0.0101	0.111	CbGeAlD
Propafenone—CYP3A4—urine—polycystic ovary syndrome	0.00773	0.0844	CbGeAlD
Propafenone—CYP2D6—urine—polycystic ovary syndrome	0.00761	0.0831	CbGeAlD
Propafenone—Dehydration—Metformin—polycystic ovary syndrome	0.00612	0.0125	CcSEcCtD
Propafenone—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00607	0.0125	CcSEcCtD
Propafenone—Breast disorder—Metformin—polycystic ovary syndrome	0.00594	0.0122	CcSEcCtD
Propafenone—Cramp muscle—Metformin—polycystic ovary syndrome	0.00592	0.0121	CcSEcCtD
Propafenone—Abdominal distension—Metformin—polycystic ovary syndrome	0.00572	0.0117	CcSEcCtD
Propafenone—Influenza—Metformin—polycystic ovary syndrome	0.00568	0.0117	CcSEcCtD
Propafenone—Pancreatitis—Metformin—polycystic ovary syndrome	0.00557	0.0114	CcSEcCtD
Propafenone—Sweating increased—Metformin—polycystic ovary syndrome	0.00554	0.0114	CcSEcCtD
Propafenone—Angina pectoris—Metformin—polycystic ovary syndrome	0.00554	0.0114	CcSEcCtD
Propafenone—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00528	0.0108	CcSEcCtD
Propafenone—Mirabegron—ADRB3—polycystic ovary syndrome	0.0052	0.108	CrCbGaD
Propafenone—Drowsiness—Metformin—polycystic ovary syndrome	0.00507	0.0104	CcSEcCtD
Propafenone—Infestation NOS—Metformin—polycystic ovary syndrome	0.00507	0.0104	CcSEcCtD
Propafenone—Infestation—Metformin—polycystic ovary syndrome	0.00507	0.0104	CcSEcCtD
Propafenone—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00497	0.0102	CcSEcCtD
Propafenone—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00479	0.00983	CcSEcCtD
Propafenone—Bradycardia—Metformin—polycystic ovary syndrome	0.00463	0.0095	CcSEcCtD
Propafenone—Rhinitis—Metformin—polycystic ovary syndrome	0.00456	0.00936	CcSEcCtD
Propafenone—Hepatitis—Metformin—polycystic ovary syndrome	0.00455	0.00933	CcSEcCtD
Propafenone—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00453	0.00929	CcSEcCtD
Propafenone—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00447	0.00917	CcSEcCtD
Propafenone—Eye disorder—Metformin—polycystic ovary syndrome	0.00425	0.00872	CcSEcCtD
Propafenone—Bopindolol—ADRB3—polycystic ovary syndrome	0.00424	0.0883	CrCbGaD
Propafenone—Flushing—Metformin—polycystic ovary syndrome	0.00422	0.00866	CcSEcCtD
Propafenone—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00422	0.00866	CcSEcCtD
Propafenone—Angiopathy—Metformin—polycystic ovary syndrome	0.00413	0.00847	CcSEcCtD
Propafenone—Immune system disorder—Metformin—polycystic ovary syndrome	0.00411	0.00843	CcSEcCtD
Propafenone—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0041	0.00841	CcSEcCtD
Propafenone—Erythema—Metformin—polycystic ovary syndrome	0.00396	0.00813	CcSEcCtD
Propafenone—Malnutrition—Metformin—polycystic ovary syndrome	0.00396	0.00813	CcSEcCtD
Propafenone—Flatulence—Metformin—polycystic ovary syndrome	0.0039	0.00801	CcSEcCtD
Propafenone—Dysgeusia—Metformin—polycystic ovary syndrome	0.00388	0.00796	CcSEcCtD
Propafenone—Muscle spasms—Metformin—polycystic ovary syndrome	0.00381	0.00781	CcSEcCtD
Propafenone—Vision blurred—Metformin—polycystic ovary syndrome	0.00373	0.00766	CcSEcCtD
Propafenone—Tremor—Metformin—polycystic ovary syndrome	0.00371	0.00761	CcSEcCtD
Propafenone—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00367	0.00754	CcSEcCtD
Propafenone—SCN5A—vagina—polycystic ovary syndrome	0.0036	0.0393	CbGeAlD
Propafenone—Malaise—Metformin—polycystic ovary syndrome	0.00357	0.00733	CcSEcCtD
Propafenone—Syncope—Metformin—polycystic ovary syndrome	0.00355	0.00729	CcSEcCtD
Propafenone—Palpitations—Metformin—polycystic ovary syndrome	0.0035	0.00718	CcSEcCtD
Propafenone—ADRB1—adipose tissue—polycystic ovary syndrome	0.00348	0.038	CbGeAlD
Propafenone—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00348	0.00714	CcSEcCtD
Propafenone—Hypertension—Metformin—polycystic ovary syndrome	0.00342	0.00702	CcSEcCtD
Propafenone—Chest pain—Metformin—polycystic ovary syndrome	0.00337	0.00692	CcSEcCtD
Propafenone—Myalgia—Metformin—polycystic ovary syndrome	0.00337	0.00692	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00335	0.00687	CcSEcCtD
Propafenone—Discomfort—Metformin—polycystic ovary syndrome	0.00333	0.00683	CcSEcCtD
Propafenone—Oedema—Metformin—polycystic ovary syndrome	0.00323	0.00663	CcSEcCtD
Propafenone—Infection—Metformin—polycystic ovary syndrome	0.00321	0.00659	CcSEcCtD
Propafenone—Shock—Metformin—polycystic ovary syndrome	0.00318	0.00652	CcSEcCtD
Propafenone—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00317	0.0065	CcSEcCtD
Propafenone—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00316	0.00649	CcSEcCtD
Propafenone—Skin disorder—Metformin—polycystic ovary syndrome	0.00314	0.00644	CcSEcCtD
Propafenone—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00312	0.00641	CcSEcCtD
Propafenone—Anorexia—Metformin—polycystic ovary syndrome	0.00308	0.00632	CcSEcCtD
Propafenone—Labetalol—ADRB3—polycystic ovary syndrome	0.00304	0.0633	CrCbGaD
Propafenone—Hypotension—Metformin—polycystic ovary syndrome	0.00302	0.0062	CcSEcCtD
Propafenone—KCNH2—endometrium—polycystic ovary syndrome	0.00295	0.0322	CbGeAlD
Propafenone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00294	0.00604	CcSEcCtD
Propafenone—Bevantolol—ADRA1A—polycystic ovary syndrome	0.00292	0.061	CrCbGaD
Propafenone—Paraesthesia—Metformin—polycystic ovary syndrome	0.0029	0.00595	CcSEcCtD
Propafenone—Dyspnoea—Metformin—polycystic ovary syndrome	0.00288	0.00591	CcSEcCtD
Propafenone—Somnolence—Metformin—polycystic ovary syndrome	0.00287	0.0059	CcSEcCtD
Propafenone—Dyspepsia—Metformin—polycystic ovary syndrome	0.00284	0.00584	CcSEcCtD
Propafenone—Decreased appetite—Metformin—polycystic ovary syndrome	0.00281	0.00576	CcSEcCtD
Propafenone—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00279	0.00573	CcSEcCtD
Propafenone—Fatigue—Metformin—polycystic ovary syndrome	0.00279	0.00572	CcSEcCtD
Propafenone—Constipation—Metformin—polycystic ovary syndrome	0.00276	0.00567	CcSEcCtD
Propafenone—KCNH2—uterus—polycystic ovary syndrome	0.00272	0.0297	CbGeAlD
Propafenone—ADRB1—endocrine gland—polycystic ovary syndrome	0.00271	0.0296	CbGeAlD
Propafenone—CYP2C8—endometrium—polycystic ovary syndrome	0.0027	0.0295	CbGeAlD
Propafenone—KCNH2—pituitary gland—polycystic ovary syndrome	0.00267	0.0292	CbGeAlD
Propafenone—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00266	0.00546	CcSEcCtD
Propafenone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00264	0.00542	CcSEcCtD
Propafenone—Urticaria—Metformin—polycystic ovary syndrome	0.00257	0.00527	CcSEcCtD
Propafenone—Abdominal pain—Metformin—polycystic ovary syndrome	0.00255	0.00524	CcSEcCtD
Propafenone—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00244	0.0267	CbGeAlD
Propafenone—KCNH2—adrenal gland—polycystic ovary syndrome	0.00239	0.0261	CbGeAlD
Propafenone—Carvedilol—ADRA1D—polycystic ovary syndrome	0.00233	0.0485	CrCbGaD
Propafenone—Asthenia—Metformin—polycystic ovary syndrome	0.00232	0.00476	CcSEcCtD
Propafenone—Pruritus—Metformin—polycystic ovary syndrome	0.00229	0.00469	CcSEcCtD
Propafenone—KCNH2—female gonad—polycystic ovary syndrome	0.00222	0.0243	CbGeAlD
Propafenone—Diarrhoea—Metformin—polycystic ovary syndrome	0.00221	0.00454	CcSEcCtD
Propafenone—KCNH2—vagina—polycystic ovary syndrome	0.00221	0.0241	CbGeAlD
Propafenone—Dizziness—Metformin—polycystic ovary syndrome	0.00214	0.00439	CcSEcCtD
Propafenone—Carvedilol—ADRB3—polycystic ovary syndrome	0.00209	0.0436	CrCbGaD
Propafenone—KCNH2—endocrine gland—polycystic ovary syndrome	0.00207	0.0226	CbGeAlD
Propafenone—Vomiting—Metformin—polycystic ovary syndrome	0.00205	0.00422	CcSEcCtD
Propafenone—Rash—Metformin—polycystic ovary syndrome	0.00204	0.00418	CcSEcCtD
Propafenone—Dermatitis—Metformin—polycystic ovary syndrome	0.00204	0.00418	CcSEcCtD
Propafenone—Headache—Metformin—polycystic ovary syndrome	0.00202	0.00415	CcSEcCtD
Propafenone—CYP2C8—vagina—polycystic ovary syndrome	0.00202	0.0221	CbGeAlD
Propafenone—Carvedilol—ADRA1B—polycystic ovary syndrome	0.00198	0.0414	CrCbGaD
Propafenone—Nausea—Metformin—polycystic ovary syndrome	0.00192	0.00394	CcSEcCtD
Propafenone—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00189	0.0207	CbGeAlD
Propafenone—Benazepril—MTHFR—polycystic ovary syndrome	0.00186	0.0388	CrCbGaD
Propafenone—Salmeterol—ADRB2—polycystic ovary syndrome	0.00181	0.0377	CrCbGaD
Propafenone—Phenoxybenzamine—ADRA1D—polycystic ovary syndrome	0.00179	0.0374	CrCbGaD
Propafenone—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00177	0.0193	CbGeAlD
Propafenone—ABCB1—embryo—polycystic ovary syndrome	0.00177	0.0193	CbGeAlD
Propafenone—Esmolol—ADRB2—polycystic ovary syndrome	0.00176	0.0367	CrCbGaD
Propafenone—Quinapril—ACE—polycystic ovary syndrome	0.00175	0.0364	CrCbGaD
Propafenone—Bevantolol—ADRB2—polycystic ovary syndrome	0.00174	0.0363	CrCbGaD
Propafenone—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00168	0.0184	CbGeAlD
Propafenone—Bopindolol—ADRB2—polycystic ovary syndrome	0.00161	0.0336	CrCbGaD
Propafenone—Propranolol—ADRB3—polycystic ovary syndrome	0.00159	0.0331	CrCbGaD
Propafenone—Phenoxybenzamine—ADRA1B—polycystic ovary syndrome	0.00153	0.0319	CrCbGaD
Propafenone—Benazepril—ACE—polycystic ovary syndrome	0.00152	0.0317	CrCbGaD
Propafenone—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00145	0.0158	CbGeAlD
Propafenone—Carvedilol—VEGFA—polycystic ovary syndrome	0.00141	0.0294	CrCbGaD
Propafenone—CYP2D6—female gonad—polycystic ovary syndrome	0.00136	0.0148	CbGeAlD
Propafenone—Carvedilol—ADRA1A—polycystic ovary syndrome	0.00134	0.0279	CrCbGaD
Propafenone—ABCB1—endometrium—polycystic ovary syndrome	0.00129	0.0141	CbGeAlD
Propafenone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00128	0.014	CbGeAlD
Propafenone—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00126	0.0138	CbGeAlD
Propafenone—ABCB1—uterus—polycystic ovary syndrome	0.00119	0.013	CbGeAlD
Propafenone—ABCB1—pituitary gland—polycystic ovary syndrome	0.00117	0.0128	CbGeAlD
Propafenone—ABCB1—adipose tissue—polycystic ovary syndrome	0.00117	0.0127	CbGeAlD
Propafenone—Labetalol—ADRB2—polycystic ovary syndrome	0.00115	0.0241	CrCbGaD
Propafenone—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.00108	0.0225	CrCbGaD
Propafenone—ABCB1—adrenal gland—polycystic ovary syndrome	0.00105	0.0114	CbGeAlD
Propafenone—Phenoxybenzamine—ADRA1A—polycystic ovary syndrome	0.00103	0.0215	CrCbGaD
Propafenone—ABCB1—female gonad—polycystic ovary syndrome	0.000976	0.0107	CbGeAlD
Propafenone—ABCB1—vagina—polycystic ovary syndrome	0.00097	0.0106	CbGeAlD
Propafenone—ABCB1—endocrine gland—polycystic ovary syndrome	0.000908	0.00991	CbGeAlD
Propafenone—Carvedilol—ADRB2—polycystic ovary syndrome	0.000795	0.0166	CrCbGaD
Propafenone—Carvedilol—CYP1A1—polycystic ovary syndrome	0.000681	0.0142	CrCbGaD
Propafenone—Phenoxybenzamine—ADRB2—polycystic ovary syndrome	0.000613	0.0128	CrCbGaD
Propafenone—Propranolol—ADRB2—polycystic ovary syndrome	0.000604	0.0126	CrCbGaD
Propafenone—Propranolol—CYP1A1—polycystic ovary syndrome	0.000518	0.0108	CrCbGaD
Propafenone—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000143	0.000383	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000143	0.000383	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000142	0.00038	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000141	0.000379	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	0.000141	0.000379	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000141	0.000378	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00014	0.000376	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000137	0.000367	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	0.000137	0.000367	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000136	0.000365	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	0.000136	0.000364	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000135	0.000363	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000135	0.000362	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000135	0.000362	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000134	0.00036	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000134	0.000358	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000133	0.000357	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000133	0.000357	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000133	0.000356	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000132	0.000355	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	0.000132	0.000354	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000132	0.000354	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	0.000131	0.000352	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000131	0.00035	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00013	0.000348	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	0.000129	0.000345	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000128	0.000343	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000127	0.00034	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000126	0.000339	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000126	0.000338	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000126	0.000338	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000125	0.000336	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000125	0.000335	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000124	0.000331	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	0.000123	0.00033	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000122	0.000326	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000121	0.000325	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.00012	0.000323	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000119	0.00032	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000118	0.000317	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000117	0.000315	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000117	0.000314	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000116	0.000312	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000115	0.000308	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000115	0.000307	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000113	0.000302	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000113	0.000302	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000112	0.000301	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000112	0.000299	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	0.000111	0.000297	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.00011	0.000295	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.00011	0.000295	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	0.00011	0.000294	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000109	0.000291	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000108	0.000291	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000107	0.000287	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—STAR—polycystic ovary syndrome	0.000107	0.000287	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000107	0.000287	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000107	0.000286	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000106	0.000284	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000105	0.000281	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	0.000105	0.00028	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000103	0.000277	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000102	0.000275	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000102	0.000274	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000102	0.000274	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000101	0.000271	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	0.0001	0.000268	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	9.89e-05	0.000265	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.8e-05	0.000263	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	9.74e-05	0.000261	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	9.58e-05	0.000257	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	9.57e-05	0.000257	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	9.55e-05	0.000256	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	9.53e-05	0.000256	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	9.49e-05	0.000254	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	9.46e-05	0.000253	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	9.37e-05	0.000251	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	9.32e-05	0.00025	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	9.11e-05	0.000244	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	9.02e-05	0.000242	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	9e-05	0.000241	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	8.99e-05	0.000241	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	8.96e-05	0.00024	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	8.92e-05	0.000239	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	8.82e-05	0.000236	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	8.82e-05	0.000236	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	8.71e-05	0.000233	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	8.71e-05	0.000233	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	8.58e-05	0.00023	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	8.55e-05	0.000229	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	8.51e-05	0.000228	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.5e-05	0.000228	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.45e-05	0.000227	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	8.41e-05	0.000226	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.41e-05	0.000225	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—LHB—polycystic ovary syndrome	8.31e-05	0.000223	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	8.31e-05	0.000223	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.21e-05	0.00022	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.17e-05	0.000219	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	8.12e-05	0.000218	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	8.04e-05	0.000216	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.97e-05	0.000214	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	7.86e-05	0.000211	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	7.83e-05	0.00021	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	7.77e-05	0.000208	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	7.76e-05	0.000208	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	7.75e-05	0.000208	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	7.72e-05	0.000207	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	7.7e-05	0.000206	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	7.65e-05	0.000205	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	7.62e-05	0.000204	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	7.58e-05	0.000203	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	7.45e-05	0.0002	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.42e-05	0.000199	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	7.41e-05	0.000199	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.41e-05	0.000198	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	7.36e-05	0.000197	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	7.34e-05	0.000197	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.3e-05	0.000196	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.3e-05	0.000196	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	7.3e-05	0.000196	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	7.27e-05	0.000195	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	7.24e-05	0.000194	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.19e-05	0.000193	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	7.01e-05	0.000188	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	6.95e-05	0.000186	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.92e-05	0.000185	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	6.84e-05	0.000183	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	6.82e-05	0.000183	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.81e-05	0.000183	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	6.77e-05	0.000181	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	6.76e-05	0.000181	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	6.75e-05	0.000181	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	6.63e-05	0.000178	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	6.6e-05	0.000177	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	6.6e-05	0.000177	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.55e-05	0.000175	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	6.49e-05	0.000174	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	6.48e-05	0.000174	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.45e-05	0.000173	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	6.41e-05	0.000172	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	6.37e-05	0.000171	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	6.33e-05	0.00017	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	6.31e-05	0.000169	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	6.28e-05	0.000168	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	6.12e-05	0.000164	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	6.06e-05	0.000162	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	6.05e-05	0.000162	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	6.04e-05	0.000162	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.03e-05	0.000162	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.99e-05	0.00016	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	5.96e-05	0.00016	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.94e-05	0.000159	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TH—polycystic ovary syndrome	5.92e-05	0.000159	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.88e-05	0.000158	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	5.78e-05	0.000155	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	5.76e-05	0.000154	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	5.7e-05	0.000153	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.65e-05	0.000152	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	5.61e-05	0.00015	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.61e-05	0.00015	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	5.59e-05	0.00015	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.57e-05	0.000149	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	5.42e-05	0.000145	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	5.41e-05	0.000145	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	5.39e-05	0.000145	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	5.31e-05	0.000142	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	5.18e-05	0.000139	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TH—polycystic ovary syndrome	5.16e-05	0.000138	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.15e-05	0.000138	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	5.12e-05	0.000137	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	5.12e-05	0.000137	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.08e-05	0.000136	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	5.02e-05	0.000134	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	5e-05	0.000134	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TH—polycystic ovary syndrome	4.86e-05	0.00013	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.84e-05	0.00013	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	4.83e-05	0.000129	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	4.83e-05	0.000129	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.82e-05	0.000129	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	4.76e-05	0.000127	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.73e-05	0.000127	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	4.73e-05	0.000127	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	4.72e-05	0.000126	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.69e-05	0.000126	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	4.6e-05	0.000123	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	4.56e-05	0.000122	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	4.53e-05	0.000121	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.46e-05	0.000119	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	4.44e-05	0.000119	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.41e-05	0.000118	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.38e-05	0.000118	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.38e-05	0.000117	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	4.36e-05	0.000117	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.32e-05	0.000116	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	4.21e-05	0.000113	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.16e-05	0.000112	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4.16e-05	0.000112	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TH—polycystic ovary syndrome	4.12e-05	0.00011	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	4.07e-05	0.000109	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	4.01e-05	0.000107	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	4e-05	0.000107	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4e-05	0.000107	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	3.97e-05	0.000106	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.95e-05	0.000106	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.93e-05	0.000105	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	3.8e-05	0.000102	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	3.78e-05	0.000101	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	3.76e-05	0.000101	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.75e-05	0.0001	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.73e-05	9.99e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.67e-05	9.84e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	3.58e-05	9.6e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.55e-05	9.52e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	3.54e-05	9.5e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	3.36e-05	9e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.35e-05	8.99e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	3.34e-05	8.95e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.31e-05	8.87e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	3.3e-05	8.84e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	3.25e-05	8.72e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—INS—polycystic ovary syndrome	3.23e-05	8.67e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	3.2e-05	8.58e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.18e-05	8.51e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.09e-05	8.28e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.03e-05	8.13e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.91e-05	7.79e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	2.87e-05	7.7e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.86e-05	7.68e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—POMC—polycystic ovary syndrome	2.83e-05	7.6e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.83e-05	7.58e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—INS—polycystic ovary syndrome	2.82e-05	7.55e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.71e-05	7.26e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.68e-05	7.19e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.67e-05	7.16e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.66e-05	7.12e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.65e-05	7.1e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.63e-05	7.06e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.59e-05	6.95e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.47e-05	6.62e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.34e-05	6.28e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	2.29e-05	6.15e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	2.26e-05	6.06e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—INS—polycystic ovary syndrome	2.25e-05	6.03e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.18e-05	5.85e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	1.98e-05	5.31e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.77e-05	4.74e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.75e-05	4.68e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.74e-05	4.65e-05	CbGpPWpGaD
